News

Recor Medical Supports ESC Guidelines for Hypertension Care

Recor Medical Supports ESC Guidelines for Hypertension Care

Recor Medical Endorses ESC Hypertension Management Guidelines

The European Society of Cardiology (ESC) recently unveiled updated guidelines for managing high blood pressure during the ESC Congress, highlighting renal denervation as a promising treatment option for those with uncontrolled hypertension.

Palo Alto, California, and Frankfurt am Main, Germany - Recor Medical, Inc. ("Recor"), along with its parent company, Otsuka Medical Devices Co., Ltd., has officially endorsed the ESC's new hypertension management recommendations. This endorsement underscores the key findings presented at the ESC Congress earlier this year, particularly the significance of renal denervation (RDN) for patients dealing with resistant hypertension.

The Impact of Hypertension

Hypertension is a serious health concern that affects more than one billion people worldwide. Often referred to as a silent killer, it frequently goes unnoticed due to its lack of symptoms. Many individuals are unaware of their condition, and despite making lifestyle changes and taking medications, a substantial number still struggle to maintain controlled blood pressure levels. Recor’s cutting-edge Paradise™ Ultrasound Renal Denervation (uRDN) system specifically targets the overactive sympathetic nerves surrounding the renal arteries, providing a solution for hypertensive patients who do not respond adequately to conventional treatments.

Key Developments at the ESC Congress

The updated ESC guidelines, titled "2024 ESC Guidelines for the Management of Elevated Blood Pressure and Hypertension," garnered considerable attention during the congress. These guidelines endorse RDN as a safe and effective treatment option for patients with resistant hypertension, especially those at an increased risk for cardiovascular issues.

Expert Opinions on the New Guidelines

Prof. Dr. Michael Böhm, a distinguished cardiologist and director of Internal Medicine III at Saarland University Hospital, shared his positive outlook on the new recommendations. He remarked, "This guidance marks a significant advancement for patients in need of safe and effective hypertension management options when standard lifestyle changes and medications are insufficient." He emphasized the importance of a multidisciplinary approach to renal denervation management and encouraged thorough discussions about the associated risks and benefits with patients.

Clinical Trials Supporting Efficacy

Recor Medical has successfully conducted three global, independently powered, randomized clinical trials involving over 500 patients with uncontrolled hypertension. These trials—RADIANCE-HTN SOLO, RADIANCE-HTN TRIO, and RADIANCE II—successfully met their primary objectives, demonstrating significant reductions in blood pressure alongside favorable safety outcomes. The Paradise system has held a CE mark since 2012, and Recor is actively working with the cardiology community throughout Europe to raise awareness and promote the adoption of ultrasound RDN therapy.

Commitment to Hypertension Management

As stated by Recor President and CEO Lara Barghout, "We are excited that the ESC guidelines recognize renal denervation as an effective treatment for uncontrolled hypertension. Addressing this global health challenge is urgent, and we are committed to transforming hypertension management by providing the benefits of our Paradise system to those who need it most."

Company Overview: Recor Medical, Inc.

Recor Medical, located in Palo Alto, California, operates as a subsidiary of Otsuka Medical Devices Co., Ltd. The company is dedicated to innovating hypertension management through the development of the Paradise Ultrasound Renal Denervation system. While still investigational in Japan, this system has received FDA approval in the United States and has obtained the CE mark for broader regulatory acceptance in Europe.

About Otsuka Medical Devices

Otsuka Medical Devices Co., Ltd. is committed to advancing medical technologies that offer novel therapeutic options where existing treatments may fall short. As a subsidiary of Otsuka Holdings Co., Ltd., which is listed on the Tokyo Stock Exchange, Otsuka Medical Devices brings a global perspective to healthcare innovation.

Frequently Asked Questions

What are the new ESC guidelines for hypertension management?

The updated ESC guidelines emphasize the importance of renal denervation as a treatment for uncontrolled hypertension and highlight its efficacy and safety.

Why is renal denervation important for hypertension treatment?

Renal denervation targets sympathetic nerves that contribute to high blood pressure, helping patients who do not respond to lifestyle changes and medication.

What recent studies support the Paradise uRDN system?

Three independent, randomized clinical trials have demonstrated the effectiveness and safety of the Paradise system in managing resistant hypertension.

Who is Recor Medical?

Recor Medical is a medical technology company focused on hypertension treatment, particularly through its innovative ultrasound renal denervation technology.

How does Recor's technology work?

The Paradise system uses ultrasound energy to disrupt overactive renal nerves, aiming to reduce blood pressure and improve patient health outcomes.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

LifeVac's 7,000 Reported Saves Deserve Careful Context

Updated Category News Views 156

Veggie straws are supposed to be harmless until they are not. LifeVac says a 19-month-old girl in South Dakota became unable to breathe on November 14 after eating the snack, with a sticky piece creating a complete airway obstruction. Her father retrieved the family's LifeVac, used the pediatric mask while she was on her back, and the company says one application...

Continue Reading
ETCO Targets the Unflashy Weak Link in Battery Storage

Updated Category News Views 0

A battery cabinet can look impressive right up until one lousy connection becomes the problem nobody budgeted for. ETCO Incorporated’s new lineup of standard and custom connectors and terminals goes after that unglamorous part of battery energy storage systems: the physical handoff points carrying power, grounding equipment, and tying auxiliary components together. It...

Continue Reading
Scalefusion’s Platinum Win Sharpens Its Brand Story

Updated Category News Views 46

A Film Is Not a Balance Sheet A slick brand film cannot patch a leaky product, but it can make a complicated platform easier to remember. That is the sensible takeaway from Scalefusion’s Platinum Level win at the 2026 MarCom Awards for “One Platform. One Agent. We are Scalefusion.” The recognition is for creative execution, not commercial performance, and anybody...

Continue Reading
BNY's December Conference Slot Merits a Careful Listen

Updated Category News Views 118

A 10:40 a.m. conference appearance can look like wallpaper on a market calendar, but BNY's scheduled December 9 discussion deserves more attention than that. Robin Vince, the chief executive, is set to speak at the Goldman Sachs Financial Services Conference in New York, and the company has plainly warned that the conversation may include forward-looking statements and...

Continue Reading
Perform.AI Tests Whether Stores Can Sell to Agents

Updated Category News Views 39

Shopping bots are about to become one more fussy customer standing in the aisle, except this one reads machine-facing files, rejects broken checkout steps, and does not care how pretty the homepage looks. Perform.AI has launched a free UCP and ACP Readiness Checker aimed at online retailers that need to know whether AI agents can find products, purchase them, and follow...

Continue Reading
Lake Ridge's Strong Quarter Meets a Book Value Hit

Updated Category News Views 105

An $8.25-per-share securities markdown is the splinter in an otherwise sturdy third-quarter report from Lake Ridge Bancorp. The bank earned $9.8 million, or $4.97 per common share, for the quarter ended September 30, 2026. That is up from $9.0 million, or $4.59 per share, in the prior quarter and $7.7 million, or $3.94 per share, a year earlier. Those are not flimsy...

Continue Reading
Spruce Spins Adrenyx En Route to Nasdaq in 2027

Updated Category News Views 143

New Frontiers: Adrenyx Biosciences Takes Shape Well, here's a new chapter in biotech drama. Spruce Biosciences, a name you might have tangled with if you're into tickers like NASDAQ:SPRB, just carved out a niche with the birth of Adrenyx Biosciences. The play? A separate company eyeing the endocrinology space, setting its sights on tackling congenital adrenal hyperplasia...

Continue Reading
Finzly Welcomes Paul Finch to Drive BankOS Growth

Updated Category News Views 51

Finzly's Strategic Move to Boost Innovation Alright, folks, it seems Finzly means business. They just roped in Paul Finch, the brains who gave us Zelle during his stint as CEO over at Early Warning Services. This guy's been around the block with a couple of the biggest names in banking, and if his past headlines are any indicator, he's got the knack for shaking things up...

Continue Reading
Vertiv's 800 VDC Push Gives AI Builders More Choices

Updated Category News Views 310

Electricity is becoming the awkward roommate inside every serious AI buildout, and Vertiv is trying to move it out of the rack before it eats the whole house. The company has expanded its 800 VDC offering beyond the PowerDirect 5000 rack product introduced in May 2026, laying out systems for the rack, the AI compute pod, and the full data hall. For investors following...

Continue Reading
Linux Foundation Unveils the Global Fraud Alliance

Updated Category News Views 153

Who would have thought the tech wizards at the Linux Foundation would step up to tackle fraud on a global scale? That's what we've got with their latest play: the Open Financial Trust Alliance (OFTA). Launched at the Singapore FinTech Festival, they've got their sights on connecting the world's disconnected fraud fight. Think of it as a translator for the tangled mess of...

Continue Reading

Top 5 Most Recently Viewed Articles

Gerald Group Achieves Milestone Financing with New Facility

Updated Category News Views 187

Gerald Group Secures Significant Financing with New Credit Structure Gerald Group, a prominent player in the global trading domain focused on metals and minerals, has achieved a remarkable milestone with the recent refinancing of its Revolving Credit Facility (RCF). This year marks the sixteenth annual iteration of this financial strategy, culminating in an impressive sum...

Continue Reading
eXp World Holdings Reports Strong Q2 Growth and Expansion Plans

Updated Category News Views 143

eXp World Holdings Reports Strong Q2 Growth In its recent earnings call, eXp World Holdings (NASDAQ: EXPI) highlighted its impressive financial results and strategic initiatives aimed at global expansion and improving agent productivity. The company achieved a significant 5% revenue growth, totaling $1.295 billion for Q2 2024, along with a noteworthy 6% rise in agent...

Continue Reading
GigaWatt's Innovative Approach to Crowdfunding Solar Investments

Updated Category News Views 183

GigaWatt's Innovative Growth Strategy in Solar Energy GigaWatt Inc. is embarking on an exciting opportunity for public investment as the demand for residential solar energy rises. The need for energy independence is escalating, with homeowners seeking alternatives as grid pressures and electricity costs continue to rise. With a focus on user-friendly solutions, GigaWatt...

Continue Reading
CIC Services Takes Bold Stand Against IRS Overreach on Captives

Updated Category News Views 186

CIC Services Takes A Stand Against IRS Regulations CIC Services, an industry leader in captive insurance management, has embarked on a significant legal battle against the Internal Revenue Service (IRS). This lawsuit is the second of its kind, focusing on the IRS's perceived regulatory overreach, which threatens to undermine the financial stability of small and mid-sized...

Continue Reading
Itaú Unibanco Declares Interest on Capital for Shareholders

Updated Category News Views 425

Itaú Unibanco Announces Payment of Interest on Capital Itaú Unibanco Holding S.A. has made an important announcement regarding the payment of interest on capital (IOC) to its stockholders. This decision reflects the Bank's ongoing commitment to its shareholders and their returns on investment. Details of the Payment During a recent meeting, the Board of Directors...

Continue Reading